Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor
Abstract Background Prompt evaluation and treatment of acute coronary syndrome has demonstrated to reduce mortality. Although several biomarkers have been studied for risk stratification and prognostic purposes, none is recommended to guide treatment based on its prognostic value. Copeptin and hepat...
Main Authors: | María-Consuelo Pintado, Lara Maceda, María Trascasa, Ignacio Arribas, Raúl De Pablo |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-04-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43044-022-00275-9 |
Similar Items
-
SIGNIFICANCE OF COPEPTIN IN DIAGNOSTICS OF MYOCARDIAL INFARCTION
by: L. V. Kremneva
Published: (2017-12-01) -
The incremental value of combination copeptin and troponin T for early diagnosis of acute myocardial infarction
by: Daniel R Mulyono, et al.
Published: (2013-06-01) -
Combined measurements of plasma copeptin and troponin-I levels for early exclusion of acute myocardial infarction
by: Walid Omar Ahmed, et al.
Published: (2016-12-01) -
Comparison of Troponin, High-Sensitivity Troponin, and Copeptin Markers at Different Times in Patients with High-Risk Chest Pain
by: Alireza Abootalebi, et al.
Published: (2019-08-01) -
Copeptin and NTproBNP in patients with acute Q - myocardial infarction complicated by acute heart failure with hyperglycemia on admission
by: Victor Syvolap, et al.
Published: (2019-05-01)